Formulations of anti-RSV antibodies and methods of use thereof

An anti-RSV antibody formulation comprising:

• a) about 50 mg/mL to about 250 mg/mL of an anti-RSV antibody, or antigen-binding fragment thereof,
• wherein the anti-RSV antibody, or antigen-binding fragment thereof, comprises a heavy chain variable region having the amino acid sequence of SEQ ID NO:
• 7 and a light chain variable region having the amino acid sequence of SEQ ID NO:
• 8;
• b) about 5 mM to about 20 mM histidine;
• c) about 4% to about 8% (w/v) sucrose;
• d) about 70 mM of L-arginine or a pharmaceutically acceptable salt of L-arginine;
• and
• e) about 0.01% to about 0.10% (w/v) polysorbate 80, and
• wherein the formulation is free of L-glutamate.